nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—HTR2B—cardial valve—systemic scleroderma	0.092	0.327	CbGeAlD
Lisuride—HTR2A—myenteric nerve plexus—systemic scleroderma	0.0281	0.1	CbGeAlD
Lisuride—HTR2A—pulmonary artery—systemic scleroderma	0.0199	0.0708	CbGeAlD
Lisuride—HTR1B—artery—systemic scleroderma	0.0153	0.0546	CbGeAlD
Lisuride—HTR1D—artery—systemic scleroderma	0.0148	0.0528	CbGeAlD
Lisuride—HTR1B—blood vessel—systemic scleroderma	0.0119	0.0425	CbGeAlD
Lisuride—HTR1D—blood vessel—systemic scleroderma	0.0116	0.0411	CbGeAlD
Lisuride—HTR2A—artery—systemic scleroderma	0.00737	0.0262	CbGeAlD
Lisuride—Pulmonary fibrosis—Methotrexate—systemic scleroderma	0.00644	0.00895	CcSEcCtD
Lisuride—Abdominal discomfort—Pentoxifylline—systemic scleroderma	0.00639	0.00889	CcSEcCtD
Lisuride—Blood pressure increased—Mycophenolic acid—systemic scleroderma	0.00634	0.00881	CcSEcCtD
Lisuride—HTR2A—endothelium—systemic scleroderma	0.00622	0.0222	CbGeAlD
Lisuride—HTR1D—connective tissue—systemic scleroderma	0.00593	0.0211	CbGeAlD
Lisuride—ADRB1—connective tissue—systemic scleroderma	0.00576	0.0205	CbGeAlD
Lisuride—HTR2A—blood vessel—systemic scleroderma	0.00574	0.0204	CbGeAlD
Lisuride—Sweating—Pentoxifylline—systemic scleroderma	0.0057	0.00793	CcSEcCtD
Lisuride—Orthostatic hypotension—Captopril—systemic scleroderma	0.00534	0.00743	CcSEcCtD
Lisuride—HTR2B—smooth muscle tissue—systemic scleroderma	0.00504	0.018	CbGeAlD
Lisuride—HTR2B—skin of body—systemic scleroderma	0.00498	0.0177	CbGeAlD
Lisuride—Immune system disorder—Pentoxifylline—systemic scleroderma	0.00482	0.00671	CcSEcCtD
Lisuride—Weight decreased—Captopril—systemic scleroderma	0.00457	0.00636	CcSEcCtD
Lisuride—Dehydration—Mycophenolic acid—systemic scleroderma	0.00428	0.00595	CcSEcCtD
Lisuride—Abdominal discomfort—Azathioprine—systemic scleroderma	0.00423	0.00588	CcSEcCtD
Lisuride—Orthostatic hypotension—Mycophenolic acid—systemic scleroderma	0.0042	0.00584	CcSEcCtD
Lisuride—Immune system disorder—Mometasone—systemic scleroderma	0.00416	0.00579	CcSEcCtD
Lisuride—Mediastinal disorder—Mometasone—systemic scleroderma	0.00415	0.00577	CcSEcCtD
Lisuride—Disturbance in sexual arousal—Lisinopril—systemic scleroderma	0.00411	0.00571	CcSEcCtD
Lisuride—Palpitations—Pentoxifylline—systemic scleroderma	0.00411	0.00571	CcSEcCtD
Lisuride—Hallucination—Captopril—systemic scleroderma	0.00403	0.0056	CcSEcCtD
Lisuride—HTR2B—digestive system—systemic scleroderma	0.00398	0.0142	CbGeAlD
Lisuride—Anxiety—Pentoxifylline—systemic scleroderma	0.00394	0.00548	CcSEcCtD
Lisuride—Dry mouth—Pentoxifylline—systemic scleroderma	0.00387	0.00538	CcSEcCtD
Lisuride—Dehydration—Lisinopril—systemic scleroderma	0.00385	0.00536	CcSEcCtD
Lisuride—Confusional state—Pentoxifylline—systemic scleroderma	0.00382	0.00532	CcSEcCtD
Lisuride—HTR2B—tendon—systemic scleroderma	0.00379	0.0135	CbGeAlD
Lisuride—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.00378	0.00526	CcSEcCtD
Lisuride—Weight decreased—Leflunomide—systemic scleroderma	0.00377	0.00524	CcSEcCtD
Lisuride—Infection—Pentoxifylline—systemic scleroderma	0.00377	0.00524	CcSEcCtD
Lisuride—Tachycardia—Pentoxifylline—systemic scleroderma	0.0037	0.00515	CcSEcCtD
Lisuride—Pleural effusion—Methotrexate—systemic scleroderma	0.0037	0.00514	CcSEcCtD
Lisuride—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00367	0.0051	CcSEcCtD
Lisuride—Weight increased—Mycophenolic acid—systemic scleroderma	0.00362	0.00503	CcSEcCtD
Lisuride—Anorexia—Pentoxifylline—systemic scleroderma	0.00362	0.00503	CcSEcCtD
Lisuride—Weight decreased—Mycophenolic acid—systemic scleroderma	0.0036	0.005	CcSEcCtD
Lisuride—Cough—Mometasone—systemic scleroderma	0.0035	0.00487	CcSEcCtD
Lisuride—ADRB1—lung—systemic scleroderma	0.00347	0.0124	CbGeAlD
Lisuride—ADRA2A—connective tissue—systemic scleroderma	0.00346	0.0123	CbGeAlD
Lisuride—Insomnia—Pentoxifylline—systemic scleroderma	0.00343	0.00477	CcSEcCtD
Lisuride—Sweating—Mycophenolic acid—systemic scleroderma	0.0034	0.00472	CcSEcCtD
Lisuride—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00338	0.0047	CcSEcCtD
Lisuride—Dehydration—Mycophenolate mofetil—systemic scleroderma	0.00337	0.00469	CcSEcCtD
Lisuride—Somnolence—Pentoxifylline—systemic scleroderma	0.00337	0.00469	CcSEcCtD
Lisuride—Dry mouth—Mometasone—systemic scleroderma	0.00334	0.00464	CcSEcCtD
Lisuride—HTR2B—lung—systemic scleroderma	0.00332	0.0118	CbGeAlD
Lisuride—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.00331	0.00461	CcSEcCtD
Lisuride—Decreased appetite—Pentoxifylline—systemic scleroderma	0.0033	0.00458	CcSEcCtD
Lisuride—Oedema peripheral—Leflunomide—systemic scleroderma	0.00328	0.00457	CcSEcCtD
Lisuride—Weight increased—Lisinopril—systemic scleroderma	0.00326	0.00453	CcSEcCtD
Lisuride—Infection—Mometasone—systemic scleroderma	0.00325	0.00452	CcSEcCtD
Lisuride—Constipation—Pentoxifylline—systemic scleroderma	0.00324	0.00451	CcSEcCtD
Lisuride—Weight decreased—Lisinopril—systemic scleroderma	0.00324	0.0045	CcSEcCtD
Lisuride—Immune system disorder—Azathioprine—systemic scleroderma	0.00319	0.00443	CcSEcCtD
Lisuride—Mediastinal disorder—Azathioprine—systemic scleroderma	0.00318	0.00443	CcSEcCtD
Lisuride—Hallucination—Mycophenolic acid—systemic scleroderma	0.00317	0.0044	CcSEcCtD
Lisuride—Syncope—Captopril—systemic scleroderma	0.00316	0.00439	CcSEcCtD
Lisuride—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.00313	0.00436	CcSEcCtD
Lisuride—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00313	0.00435	CcSEcCtD
Lisuride—Anorexia—Mometasone—systemic scleroderma	0.00312	0.00434	CcSEcCtD
Lisuride—Palpitations—Captopril—systemic scleroderma	0.00311	0.00433	CcSEcCtD
Lisuride—Cardiac disorder—Leflunomide—systemic scleroderma	0.00309	0.0043	CcSEcCtD
Lisuride—Cough—Captopril—systemic scleroderma	0.00307	0.00427	CcSEcCtD
Lisuride—Sweating—Lisinopril—systemic scleroderma	0.00306	0.00425	CcSEcCtD
Lisuride—Immune system disorder—Leflunomide—systemic scleroderma	0.00301	0.00419	CcSEcCtD
Lisuride—Mediastinal disorder—Leflunomide—systemic scleroderma	0.00301	0.00418	CcSEcCtD
Lisuride—ADRA2C—tendon—systemic scleroderma	0.00298	0.0106	CbGeAlD
Lisuride—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.00295	0.00411	CcSEcCtD
Lisuride—HTR2A—connective tissue—systemic scleroderma	0.00294	0.0105	CbGeAlD
Lisuride—Dry mouth—Captopril—systemic scleroderma	0.00293	0.00408	CcSEcCtD
Lisuride—Mental disorder—Leflunomide—systemic scleroderma	0.00292	0.00406	CcSEcCtD
Lisuride—Dyspnoea—Mometasone—systemic scleroderma	0.00292	0.00406	CcSEcCtD
Lisuride—Malnutrition—Leflunomide—systemic scleroderma	0.0029	0.00404	CcSEcCtD
Lisuride—Confusional state—Captopril—systemic scleroderma	0.0029	0.00403	CcSEcCtD
Lisuride—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00289	0.00401	CcSEcCtD
Lisuride—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.00287	0.00399	CcSEcCtD
Lisuride—Weight increased—Mycophenolate mofetil—systemic scleroderma	0.00285	0.00397	CcSEcCtD
Lisuride—Hallucination—Lisinopril—systemic scleroderma	0.00285	0.00396	CcSEcCtD
Lisuride—Decreased appetite—Mometasone—systemic scleroderma	0.00285	0.00396	CcSEcCtD
Lisuride—Weight decreased—Mycophenolate mofetil—systemic scleroderma	0.00284	0.00395	CcSEcCtD
Lisuride—Oedema peripheral—Lisinopril—systemic scleroderma	0.00282	0.00392	CcSEcCtD
Lisuride—Fatigue—Mometasone—systemic scleroderma	0.00282	0.00392	CcSEcCtD
Lisuride—Tachycardia—Captopril—systemic scleroderma	0.00281	0.0039	CcSEcCtD
Lisuride—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00279	0.00388	CcSEcCtD
Lisuride—Malnutrition—Mycophenolic acid—systemic scleroderma	0.00277	0.00385	CcSEcCtD
Lisuride—Anorexia—Captopril—systemic scleroderma	0.00274	0.00381	CcSEcCtD
Lisuride—Asthenia—Pentoxifylline—systemic scleroderma	0.00272	0.00378	CcSEcCtD
Lisuride—HTR2A—smooth muscle tissue—systemic scleroderma	0.00269	0.00959	CbGeAlD
Lisuride—DRD2—lung—systemic scleroderma	0.00269	0.00958	CbGeAlD
Lisuride—Sweating—Mycophenolate mofetil—systemic scleroderma	0.00268	0.00373	CcSEcCtD
Lisuride—ADRA2C—lung—systemic scleroderma	0.00262	0.00932	CbGeAlD
Lisuride—Vertigo—Leflunomide—systemic scleroderma	0.00261	0.00363	CcSEcCtD
Lisuride—Insomnia—Captopril—systemic scleroderma	0.0026	0.00362	CcSEcCtD
Lisuride—Angiopathy—Lisinopril—systemic scleroderma	0.0026	0.00361	CcSEcCtD
Lisuride—Mediastinal disorder—Lisinopril—systemic scleroderma	0.00258	0.00359	CcSEcCtD
Lisuride—Palpitations—Leflunomide—systemic scleroderma	0.00257	0.00357	CcSEcCtD
Lisuride—Dyspnoea—Captopril—systemic scleroderma	0.00256	0.00356	CcSEcCtD
Lisuride—Somnolence—Captopril—systemic scleroderma	0.00256	0.00355	CcSEcCtD
Lisuride—Cough—Leflunomide—systemic scleroderma	0.00253	0.00352	CcSEcCtD
Lisuride—Mental disorder—Lisinopril—systemic scleroderma	0.00251	0.00349	CcSEcCtD
Lisuride—Dizziness—Pentoxifylline—systemic scleroderma	0.00251	0.00349	CcSEcCtD
Lisuride—Decreased appetite—Captopril—systemic scleroderma	0.0025	0.00347	CcSEcCtD
Lisuride—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.0025	0.00347	CcSEcCtD
Lisuride—Malnutrition—Lisinopril—systemic scleroderma	0.00249	0.00347	CcSEcCtD
Lisuride—Infection—Azathioprine—systemic scleroderma	0.00249	0.00347	CcSEcCtD
Lisuride—Vertigo—Mycophenolic acid—systemic scleroderma	0.00249	0.00346	CcSEcCtD
Lisuride—Syncope—Mycophenolic acid—systemic scleroderma	0.00248	0.00345	CcSEcCtD
Lisuride—Fatigue—Captopril—systemic scleroderma	0.00248	0.00345	CcSEcCtD
Lisuride—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00247	0.00344	CcSEcCtD
Lisuride—Anxiety—Leflunomide—systemic scleroderma	0.00246	0.00342	CcSEcCtD
Lisuride—Constipation—Captopril—systemic scleroderma	0.00246	0.00342	CcSEcCtD
Lisuride—Palpitations—Mycophenolic acid—systemic scleroderma	0.00245	0.0034	CcSEcCtD
Lisuride—Dry mouth—Leflunomide—systemic scleroderma	0.00242	0.00336	CcSEcCtD
Lisuride—Cough—Mycophenolic acid—systemic scleroderma	0.00242	0.00336	CcSEcCtD
Lisuride—Vomiting—Pentoxifylline—systemic scleroderma	0.00241	0.00335	CcSEcCtD
Lisuride—ADRA2A—tendon—systemic scleroderma	0.00238	0.00847	CbGeAlD
Lisuride—Headache—Pentoxifylline—systemic scleroderma	0.00238	0.0033	CcSEcCtD
Lisuride—Feeling abnormal—Captopril—systemic scleroderma	0.00237	0.00329	CcSEcCtD
Lisuride—Infection—Leflunomide—systemic scleroderma	0.00235	0.00327	CcSEcCtD
Lisuride—Anxiety—Mycophenolic acid—systemic scleroderma	0.00235	0.00327	CcSEcCtD
Lisuride—Asthenia—Mometasone—systemic scleroderma	0.00235	0.00327	CcSEcCtD
Lisuride—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00233	0.00324	CcSEcCtD
Lisuride—Nervous system disorder—Leflunomide—systemic scleroderma	0.00232	0.00323	CcSEcCtD
Lisuride—Tachycardia—Leflunomide—systemic scleroderma	0.00231	0.00322	CcSEcCtD
Lisuride—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00231	0.00321	CcSEcCtD
Lisuride—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00229	0.00318	CcSEcCtD
Lisuride—Confusional state—Mycophenolic acid—systemic scleroderma	0.00228	0.00317	CcSEcCtD
Lisuride—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00228	0.00317	CcSEcCtD
Lisuride—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00226	0.00315	CcSEcCtD
Lisuride—Anorexia—Leflunomide—systemic scleroderma	0.00226	0.00314	CcSEcCtD
Lisuride—Infection—Mycophenolic acid—systemic scleroderma	0.00225	0.00312	CcSEcCtD
Lisuride—Vertigo—Lisinopril—systemic scleroderma	0.00224	0.00312	CcSEcCtD
Lisuride—Syncope—Lisinopril—systemic scleroderma	0.00224	0.00311	CcSEcCtD
Lisuride—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00222	0.00308	CcSEcCtD
Lisuride—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00221	0.00307	CcSEcCtD
Lisuride—Palpitations—Lisinopril—systemic scleroderma	0.0022	0.00307	CcSEcCtD
Lisuride—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.0022	0.00306	CcSEcCtD
Lisuride—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.00219	0.00304	CcSEcCtD
Lisuride—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00218	0.00304	CcSEcCtD
Lisuride—Cough—Lisinopril—systemic scleroderma	0.00218	0.00303	CcSEcCtD
Lisuride—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00217	0.00301	CcSEcCtD
Lisuride—Anorexia—Mycophenolic acid—systemic scleroderma	0.00215	0.003	CcSEcCtD
Lisuride—Insomnia—Leflunomide—systemic scleroderma	0.00214	0.00298	CcSEcCtD
Lisuride—HTR2A—digestive system—systemic scleroderma	0.00213	0.00757	CbGeAlD
Lisuride—Anxiety—Lisinopril—systemic scleroderma	0.00212	0.00294	CcSEcCtD
Lisuride—Dyspnoea—Leflunomide—systemic scleroderma	0.00211	0.00294	CcSEcCtD
Lisuride—ADRA2A—lung—systemic scleroderma	0.00209	0.00743	CbGeAlD
Lisuride—Vomiting—Mometasone—systemic scleroderma	0.00208	0.00289	CcSEcCtD
Lisuride—Dry mouth—Lisinopril—systemic scleroderma	0.00208	0.00289	CcSEcCtD
Lisuride—Feeling abnormal—Azathioprine—systemic scleroderma	0.00207	0.00287	CcSEcCtD
Lisuride—Asthenia—Captopril—systemic scleroderma	0.00206	0.00287	CcSEcCtD
Lisuride—Decreased appetite—Leflunomide—systemic scleroderma	0.00206	0.00286	CcSEcCtD
Lisuride—Confusional state—Lisinopril—systemic scleroderma	0.00205	0.00285	CcSEcCtD
Lisuride—Headache—Mometasone—systemic scleroderma	0.00205	0.00285	CcSEcCtD
Lisuride—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00205	0.00284	CcSEcCtD
Lisuride—Insomnia—Mycophenolic acid—systemic scleroderma	0.00204	0.00284	CcSEcCtD
Lisuride—Fatigue—Leflunomide—systemic scleroderma	0.00204	0.00284	CcSEcCtD
Lisuride—Constipation—Leflunomide—systemic scleroderma	0.00203	0.00282	CcSEcCtD
Lisuride—HTR2A—tendon—systemic scleroderma	0.00202	0.0072	CbGeAlD
Lisuride—Infection—Lisinopril—systemic scleroderma	0.00202	0.00281	CcSEcCtD
Lisuride—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00201	0.0028	CcSEcCtD
Lisuride—Somnolence—Mycophenolic acid—systemic scleroderma	0.00201	0.00279	CcSEcCtD
Lisuride—Tachycardia—Lisinopril—systemic scleroderma	0.00199	0.00276	CcSEcCtD
Lisuride—CYP3A4—digestive system—systemic scleroderma	0.00197	0.00701	CbGeAlD
Lisuride—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00197	0.00274	CcSEcCtD
Lisuride—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00196	0.00273	CcSEcCtD
Lisuride—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00196	0.00273	CcSEcCtD
Lisuride—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00196	0.00273	CcSEcCtD
Lisuride—Feeling abnormal—Leflunomide—systemic scleroderma	0.00195	0.00271	CcSEcCtD
Lisuride—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00195	0.00271	CcSEcCtD
Lisuride—Fatigue—Mycophenolic acid—systemic scleroderma	0.00195	0.00271	CcSEcCtD
Lisuride—Anorexia—Lisinopril—systemic scleroderma	0.00194	0.0027	CcSEcCtD
Lisuride—CYP2D6—digestive system—systemic scleroderma	0.00194	0.0069	CbGeAlD
Lisuride—Weight increased—Prednisone—systemic scleroderma	0.00193	0.00269	CcSEcCtD
Lisuride—Constipation—Mycophenolic acid—systemic scleroderma	0.00193	0.00269	CcSEcCtD
Lisuride—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00193	0.00269	CcSEcCtD
Lisuride—Weight decreased—Prednisone—systemic scleroderma	0.00192	0.00267	CcSEcCtD
Lisuride—Cough—Mycophenolate mofetil—systemic scleroderma	0.00191	0.00265	CcSEcCtD
Lisuride—Dizziness—Captopril—systemic scleroderma	0.0019	0.00264	CcSEcCtD
Lisuride—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00186	0.00259	CcSEcCtD
Lisuride—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00185	0.00258	CcSEcCtD
Lisuride—Insomnia—Lisinopril—systemic scleroderma	0.00184	0.00256	CcSEcCtD
Lisuride—Vomiting—Captopril—systemic scleroderma	0.00183	0.00254	CcSEcCtD
Lisuride—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00182	0.00253	CcSEcCtD
Lisuride—Dyspnoea—Lisinopril—systemic scleroderma	0.00181	0.00252	CcSEcCtD
Lisuride—Somnolence—Lisinopril—systemic scleroderma	0.00181	0.00252	CcSEcCtD
Lisuride—Headache—Captopril—systemic scleroderma	0.0018	0.0025	CcSEcCtD
Lisuride—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.0018	0.0025	CcSEcCtD
Lisuride—HTR2A—lung—systemic scleroderma	0.00178	0.00632	CbGeAlD
Lisuride—Infection—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00246	CcSEcCtD
Lisuride—Decreased appetite—Lisinopril—systemic scleroderma	0.00177	0.00246	CcSEcCtD
Lisuride—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00176	0.00244	CcSEcCtD
Lisuride—Fatigue—Lisinopril—systemic scleroderma	0.00176	0.00244	CcSEcCtD
Lisuride—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00175	0.00243	CcSEcCtD
Lisuride—Constipation—Lisinopril—systemic scleroderma	0.00174	0.00242	CcSEcCtD
Lisuride—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00174	0.00242	CcSEcCtD
Lisuride—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00172	0.0024	CcSEcCtD
Lisuride—Abdominal discomfort—Methotrexate—systemic scleroderma	0.0017	0.00237	CcSEcCtD
Lisuride—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.0017	0.00236	CcSEcCtD
Lisuride—Asthenia—Leflunomide—systemic scleroderma	0.0017	0.00236	CcSEcCtD
Lisuride—Hallucination—Prednisone—systemic scleroderma	0.00169	0.00235	CcSEcCtD
Lisuride—Feeling abnormal—Lisinopril—systemic scleroderma	0.00168	0.00233	CcSEcCtD
Lisuride—Dizziness—Azathioprine—systemic scleroderma	0.00166	0.00231	CcSEcCtD
Lisuride—Asthenia—Mycophenolic acid—systemic scleroderma	0.00162	0.00225	CcSEcCtD
Lisuride—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00161	0.00224	CcSEcCtD
Lisuride—Vomiting—Azathioprine—systemic scleroderma	0.0016	0.00222	CcSEcCtD
Lisuride—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00221	CcSEcCtD
Lisuride—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00159	0.0022	CcSEcCtD
Lisuride—Headache—Azathioprine—systemic scleroderma	0.00157	0.00219	CcSEcCtD
Lisuride—Dizziness—Leflunomide—systemic scleroderma	0.00157	0.00218	CcSEcCtD
Lisuride—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00155	0.00216	CcSEcCtD
Lisuride—Angiopathy—Prednisone—systemic scleroderma	0.00154	0.00215	CcSEcCtD
Lisuride—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00154	0.00214	CcSEcCtD
Lisuride—Immune system disorder—Prednisone—systemic scleroderma	0.00154	0.00214	CcSEcCtD
Lisuride—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00212	CcSEcCtD
Lisuride—Sweating—Methotrexate—systemic scleroderma	0.00152	0.00211	CcSEcCtD
Lisuride—Vomiting—Leflunomide—systemic scleroderma	0.00151	0.00209	CcSEcCtD
Lisuride—Dizziness—Mycophenolic acid—systemic scleroderma	0.00149	0.00208	CcSEcCtD
Lisuride—Mental disorder—Prednisone—systemic scleroderma	0.00149	0.00207	CcSEcCtD
Lisuride—Headache—Leflunomide—systemic scleroderma	0.00148	0.00206	CcSEcCtD
Lisuride—Malnutrition—Prednisone—systemic scleroderma	0.00148	0.00206	CcSEcCtD
Lisuride—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00147	0.00204	CcSEcCtD
Lisuride—Asthenia—Lisinopril—systemic scleroderma	0.00146	0.00203	CcSEcCtD
Lisuride—Vomiting—Mycophenolic acid—systemic scleroderma	0.00144	0.002	CcSEcCtD
Lisuride—Headache—Mycophenolic acid—systemic scleroderma	0.00142	0.00197	CcSEcCtD
Lisuride—Dizziness—Lisinopril—systemic scleroderma	0.00135	0.00187	CcSEcCtD
Lisuride—Vertigo—Prednisone—systemic scleroderma	0.00133	0.00185	CcSEcCtD
Lisuride—Syncope—Prednisone—systemic scleroderma	0.00133	0.00185	CcSEcCtD
Lisuride—Cardiac disorder—Methotrexate—systemic scleroderma	0.00132	0.00184	CcSEcCtD
Lisuride—Vomiting—Lisinopril—systemic scleroderma	0.00129	0.0018	CcSEcCtD
Lisuride—Angiopathy—Methotrexate—systemic scleroderma	0.00129	0.00179	CcSEcCtD
Lisuride—Immune system disorder—Methotrexate—systemic scleroderma	0.00128	0.00179	CcSEcCtD
Lisuride—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00128	0.00178	CcSEcCtD
Lisuride—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00128	0.00178	CcSEcCtD
Lisuride—Headache—Lisinopril—systemic scleroderma	0.00128	0.00177	CcSEcCtD
Lisuride—Anxiety—Prednisone—systemic scleroderma	0.00126	0.00175	CcSEcCtD
Lisuride—Mental disorder—Methotrexate—systemic scleroderma	0.00125	0.00173	CcSEcCtD
Lisuride—Malnutrition—Methotrexate—systemic scleroderma	0.00124	0.00172	CcSEcCtD
Lisuride—Infection—Prednisone—systemic scleroderma	0.0012	0.00167	CcSEcCtD
Lisuride—Nervous system disorder—Prednisone—systemic scleroderma	0.00119	0.00165	CcSEcCtD
Lisuride—Tachycardia—Prednisone—systemic scleroderma	0.00118	0.00164	CcSEcCtD
Lisuride—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00118	0.00164	CcSEcCtD
Lisuride—Hyperhidrosis—Prednisone—systemic scleroderma	0.00117	0.00163	CcSEcCtD
Lisuride—Anorexia—Prednisone—systemic scleroderma	0.00115	0.0016	CcSEcCtD
Lisuride—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00158	CcSEcCtD
Lisuride—Headache—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00155	CcSEcCtD
Lisuride—Vertigo—Methotrexate—systemic scleroderma	0.00111	0.00155	CcSEcCtD
Lisuride—Insomnia—Prednisone—systemic scleroderma	0.00109	0.00152	CcSEcCtD
Lisuride—Cough—Methotrexate—systemic scleroderma	0.00108	0.0015	CcSEcCtD
Lisuride—Decreased appetite—Prednisone—systemic scleroderma	0.00105	0.00146	CcSEcCtD
Lisuride—Fatigue—Prednisone—systemic scleroderma	0.00104	0.00145	CcSEcCtD
Lisuride—Constipation—Prednisone—systemic scleroderma	0.00103	0.00144	CcSEcCtD
Lisuride—Confusional state—Methotrexate—systemic scleroderma	0.00102	0.00142	CcSEcCtD
Lisuride—Infection—Methotrexate—systemic scleroderma	0.001	0.0014	CcSEcCtD
Lisuride—Feeling abnormal—Prednisone—systemic scleroderma	0.000996	0.00139	CcSEcCtD
Lisuride—Nervous system disorder—Methotrexate—systemic scleroderma	0.000991	0.00138	CcSEcCtD
Lisuride—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000977	0.00136	CcSEcCtD
Lisuride—Anorexia—Methotrexate—systemic scleroderma	0.000963	0.00134	CcSEcCtD
Lisuride—Insomnia—Methotrexate—systemic scleroderma	0.000914	0.00127	CcSEcCtD
Lisuride—Dyspnoea—Methotrexate—systemic scleroderma	0.000901	0.00125	CcSEcCtD
Lisuride—Somnolence—Methotrexate—systemic scleroderma	0.000898	0.00125	CcSEcCtD
Lisuride—Decreased appetite—Methotrexate—systemic scleroderma	0.000878	0.00122	CcSEcCtD
Lisuride—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000872	0.00121	CcSEcCtD
Lisuride—Fatigue—Methotrexate—systemic scleroderma	0.000871	0.00121	CcSEcCtD
Lisuride—Asthenia—Prednisone—systemic scleroderma	0.000867	0.00121	CcSEcCtD
Lisuride—Feeling abnormal—Methotrexate—systemic scleroderma	0.000833	0.00116	CcSEcCtD
Lisuride—Dizziness—Prednisone—systemic scleroderma	0.000799	0.00111	CcSEcCtD
Lisuride—Vomiting—Prednisone—systemic scleroderma	0.000769	0.00107	CcSEcCtD
Lisuride—Headache—Prednisone—systemic scleroderma	0.000757	0.00105	CcSEcCtD
Lisuride—Asthenia—Methotrexate—systemic scleroderma	0.000725	0.00101	CcSEcCtD
Lisuride—Dizziness—Methotrexate—systemic scleroderma	0.000668	0.000929	CcSEcCtD
Lisuride—Vomiting—Methotrexate—systemic scleroderma	0.000642	0.000893	CcSEcCtD
Lisuride—Headache—Methotrexate—systemic scleroderma	0.000633	0.00088	CcSEcCtD
